Keratosis Lesion on the Nose
Journal Title: UNKNOWN - Year 2017, Vol 7, Issue 3
Abstract
Porokeratosis (PK) is a rare skin disease, of unknown etiology, probably due to a disorder of epidermal keratinization. We describe a 24 year-old male patient, with porokeratosis of Mibelli confirmed histopathologically. A young man of 24, from a non-consanguineous marriage, presented to our department with 4 years history of one hyperkeratotic lesion, symmetric, painless and non-pruritic on the nose. Clinical examination revealed the presence in the left wing of the nose, one annular lesion, measuring about 0.5 cm, the centres was atrophic and surrounded by a raised hyperkeratotic border.
Authors and Affiliations
Amina Kissou, Mansouri Siham
Implant-type Tissue-engineered Cartilage for Secondary Correction of Cleft Lip-nose Patients: An Exploratory First-in-human Trial
Objective: Secondary correction of cleft lip-nose presents a formidable challenge in cleft lip and palate surgery. Although numerous approaches have been proposed, suitable graft materials cannot be obtained from any par...
Diffuse Juvenile Xanthogranuloma: A Case Report
Juvenile xanthogranuloma (JXG) is a benign Non-langerhancian histiocytic proliferation. Herein, we report the case of a 17-month-old infant, who presented with two months history of a diffuse asymptomatic papular eruptio...
Erythroderma Due to the Association of Pegylated Interferon Alpha-2a and Ribavirin
The dermatological adverse effects due to the association of interferon Alpha and ribavirin in patients treated for hepatitis C are becoming more frequent but little is known about them. Such adverse effects range from e...
Neurofibromatosis Type 1 and Recurrent Metastatic Low-Grade Fibromyxoid Sarcoma: Case Report about a Rare Association
Neurofibromatosis type 1 is the most frequent phacomytosis. Patients with neurofibromatosis type 1 (NF1) have a high risk to develop benign or malignant tumors of neurogenic or non-neurogenic origin. The association of (...
Drug-Eluting vs. Bare-Metal Stents: Is it a Matter of Vessel Size?
Background: Although drug-eluting stents (DES) for percutaneous coronary intervention have dramatically reduced the incidence of in-stent restenosis, their deployment for large-size coronary lesions is still controversia...